TBK1 loss-of-function mutations in ALS disrupt microglial metabolic homeostasis by impairing mTOR-dependent metabolic checkpoint signaling and mitochondrial quality control. Under normal conditions, TBK1 phosphorylates ULK1 and AMPK to coordinate autophagy-mediated mitochondrial turnover with oxidative metabolism, enabling microglia to maintain anti-inflammatory M2 polarization. In ALS patients with TBK1 mutations, defective mitophagy leads to accumulation of damaged mitochondria and compensator
TBK1 deficiency in microglia creates a pathological cascade that directly generates ALS-driving TDP-43 pathology through senescence-associated secretory phenotype (SASP) mechanisms. When TBK1 is lost or mutated, microglia become locked in a senescent state characterized by dysregulated NF-κB and IRF3 signaling, defective p62-mediated autophagy, and chronic cGAS-STING pathway activation. This senescent microglial state produces a toxic SASP cocktail enriched in matrix metalloproteinase-9 (MMP-9),
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
AutophagyALS
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
# Novel Therapeutic Hypotheses: Microglial Senescence in ALS
*Generated from systematic analysis of provided literature and cross-disciplinary synthesis*
---
## Hypothesis 1: TBK1-Deficiency Drives...
Skeptic
...
Domain Expert
...
Epidemiologist
...
TBK1 Loss Drives MMP-9-Mediated TDP-43 Fragmentati
6 rounds · quality: 0.75
Theorist
# Novel Therapeutic Hypotheses: Microglial Senescence in ALS
*Generated from systematic analysis of provided literature and cross-disciplinary synthesis*
---
## Hypothesis 1: TBK1-Deficiency Drives...